{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:21:10Z","timestamp":1791512470247,"version":"4.3.4"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.2308","type":"journal-article","created":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T22:04:26Z","timestamp":1429049066000},"page":"965-970","source":"Crossref","is-referenced-by-count":26,"title":["Rituximab-associated Progressive Multifocal Leukoencephalopathy Derived from Non-Hodgkin Lymphoma: Neuropathological Findings and Results of Mefloquine Treatment"],"prefix":"10.2169","volume":"54","author":[{"given":"Yasuteru","family":"Sano","sequence":"first","affiliation":[{"name":"Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Omoto","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Takao","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, the Brain Bank for Aging Research, Tokyo Metropolitan Geriatric Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yamaguchi University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsunori","family":"Oga","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yamaguchi University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Nakamichi","sequence":"additional","affiliation":[{"name":"Department of Virology I, National Institute of Infectious Disease, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Saijo","sequence":"additional","affiliation":[{"name":"Department of Virology I, National Institute of Infectious Disease, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Maoka","sequence":"additional","affiliation":[{"name":"Research Institute for Production Development, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Sano","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoharu","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kanda","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Aström KE, Mancall EL, Richardson EP Jr. Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 81: 93-111, 1995.","DOI":"10.1093\/brain\/81.1.93"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Carson KR, Focosi D, Major EO, et al. Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol 10: 816-824, 2009.","DOI":"10.1016\/S1470-2045(09)70161-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Carson KR, Evens AM, Richey EA, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 113: 4834-4840, 2009.","DOI":"10.1182\/blood-2008-10-186999"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Brickelmaier M, Lugovskoy A, Kartikeyan R, et al. Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother 53: 1840-1849, 2009.","DOI":"10.1128\/AAC.01614-08"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Schröder A, Lee DH, Hellwig K, Lukas C, Linker RA, Gold R. Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis. Arch Neurol 67: 1391-1394, 2010.","DOI":"10.1001\/archneurol.2010.157"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Gofton TE, Al-Khotani A, O'Farrell B, Ang LC, McLachlan RS. Mefloquine in the treatment of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry 82: 452-455, 2011.","DOI":"10.1136\/jnnp.2009.190652"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Clifford DB, Ances B, Costello C, et al. Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol 68: 1156-1164, 2011.","DOI":"10.1001\/archneurol.2011.103"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kishida S, Tanaka K. Mefloquine treatment in a patient suffering from progressive multifocal leukoencephalopathy after umbilical cord blood transplant. Intern Med 49: 2509-2513, 2010.","DOI":"10.2169\/internalmedicine.49.3227"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Beppu M, Kawamoto M, Nukuzuma S, Kohara N. Mefloquine improved progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. Intern Med 51: 1245-1247, 2012.","DOI":"10.2169\/internalmedicine.51.6810"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Berger JR, Aksamit AJ, Clifford DB, et al. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology 80: 1430-1438, 2013.","DOI":"10.1212\/WNL.0b013e31828c2fa1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Cettomai D, McArthur JC. Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy. Arch Neurol 66: 255-258, 2009.","DOI":"10.1001\/archneurol.2008.557"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Elphick GF, Querbes W, Jordan JA, et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306: 1380-1383, 2004.","DOI":"10.1126\/science.1103492"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nakazawa S, Maoka T, Uemura H, Ito Y, Kanbara H. Malaria parasites giving rise to recrudescence in vitro. Antimicrob Agents Chemother 46: 958-965, 2002.","DOI":"10.1128\/AAC.46.4.958-965.2002"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Vendrely A, Bienvenu B, Gasnault J, Thiebault JB, Salmon D, Gray F. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol 109: 449-455, 2005.","DOI":"10.1007\/s00401-005-0983-y"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Metz I, Radue EW, Oterino A, et al. Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy. Acta Neuropathol 123: 235-245, 2012.","DOI":"10.1007\/s00401-011-0900-5"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Laszlo D, Bassi S, Andreola G, et al. Peripheral T-lymphocyte subsets in patients treated with Rituximab-Chlorambucil combination therapy for indolent NHL. Ann Hematol 85: 813-814, 2006.","DOI":"10.1007\/s00277-006-0170-9"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Pennie RA, Koren G, Crevoisier C. Steady state pharmacokinetics of mefloquine in long-term travellers. Trans R Soc Trop Med Hyg 87: 459-462, 1993.","DOI":"10.1016\/0035-9203(93)90036-P"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Jones R, Kunsman G, Levine B, Smith M, Stahl C. Mefloquine distribution in postmortem cases. Forensic Sci Int 68: 29-32, 1994.","DOI":"10.1016\/0379-0738(94)90376-X"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Friedman R. News from the AAN Annual Meeting: malaria drug fails to fulfill promise in PML. Neurol Today 11: 8, 2011.","DOI":"10.1097\/01.NT.0000397959.27386.55"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kobayashi Z, Akaza M, Numasawa Y, et al. Failure of mefloquine therapy in progressive multifocal leukoencephalopathy: report of two Japanese patients without human immunodeficiency virus infection. J Neurol Sci 324: 190-194, 2013.","DOI":"10.1016\/j.jns.2012.11.004"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Clifford DB, Nath A, Cinque P, et al. A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes. J Neurovirol 19: 351-358, 2013.","DOI":"10.1007\/s13365-013-0173-y"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T12:54:38Z","timestamp":1566564878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/8\/54_54.2308\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.2308","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}